4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-25-000016
Chief Financial Officer gave up 6,422 shares (to pay taxes)
- Chief Financial Officer acquired 87,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Adams Kendra · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-13 | Shares withheld for taxes : show line 1 in the form | −1,863 | $3.20 | $5,962 | 82,576 | D |
| 2025-02-14 | Grant or award : show line 2 in the form | +87,100 | 169,676 | D | ||
| 2025-02-14 | Shares withheld for taxes : show line 3 in the form | −4,559 | $3.18 | $14,498 | 165,117 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-14 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +130,600 | 130,600 | D |
Loading xslF345X05/wk-form4_1739915682.xml…